Oral health in patients with Crohn´s disease by Szymanska, Sara
From DEPARTMENT OF DENTAL MEDICINE 
Karolinska Institutet, Stockholm, Sweden 
ORAL HEALTH IN PATIENTS WITH 
CROHN´S DISEASE 
Sara Szymanska 
 
Stockholm 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by AJ E-Print AB 
© Sara Szymanska, 2015 
ISBN 978-91-7549-948-2 
 
  
 
ORAL HEALTH IN PATIENTS WITH CROHN´S DISEASE 
 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
Public defence occurs Friday 29  ͭ ͪ May 2015 at 9.30 am 
Karolinska Institutet, in 9Q Lecture Hall, Alfred Nobels Allé 8 
by 
Sara Szymanska 
MB, RDH 
Principal Supervisor: 
Associate Professor Annsofi Johannsen 
Karolinska Institutet 
Department of Dental Medicine 
Division of  Periodontology 
 
Co-supervisors: 
Professor Anders Gustafsson 
Karolinska Institutet 
Department of Dental Medicine 
Division of  Periodontology 
 
Associate Professor Mikael Lördal 
Karolinska University Hospital 
Department of Medicine 
Division of Gastroenterology and Hepatology 
Opponent: 
Professor Jukka H. Meurman 
University of Helsinki 
Institute of Dentistry 
Department of Periodontology 
 
Examination Board: 
Professor Pia Gabre 
University of Gothenburg 
Institute of Odontology at Sahlgrenska 
Academin 
 
Professor Andreas Stavropoulos 
University of Malmö  
Department of Odontology 
Division of Periodontology 
 
Associate Professor Michael Eberhardson 
Karolinska University Hospital  
Department of Medicine 
Division of Gastroenetrology and Hepatology 

  
 
 
 
 
 
“One never notices what has been done;  
one can only see what remains to be done.” 
Marie Skłodowska-Curie 
 
  
 
 
 
 
 
 
 
 
 
 
  
  With love to Anna & Anton 
 
 
 
 
 
 
 
 
 
  
  
  
  
ABSTRACT 
 
Dental caries and periodontal diseases are the most common oral diseases worldwide. They 
are multifactorial diseases which include several risk factors. Dental caries causes tooth ache 
and tooth loss, with numerous risk factors are such as cariogenic bacteria, decreased salivary 
flow, poor dietary habits, increased sugar consumption, and neglect of oral hygiene. 
Periodontal diseases, including gingivitis and periodontitis, are inflammatory processes of 
the gingiva and supporting structures of the teeth and is characterized by destruction of the 
tissues and eventually tooth loss. Risk factors for periodontitis result from a combination of 
genetic factors and environmental factors such as poor oral hygiene, amounts of 
periopathogenes, smoking and systemic diseases. Crohn´s Disease (CD) is a granulomatous 
chronic inflammatory disease that can affect the whole gastrointestinal tract, although it is 
usually localized to small and large intestine. There is no cure for CD. The aetiology of CD 
is poorly understood but an interaction between genetic, microbial and environmental factors 
may participate in the development and progression of CD. 
The general hypothesis of these studies was that patients with CD have poorer oral health 
than people without CD. The present thesis includes three studies which all aim to 
investigate oral health in patients with CD. 
Study I is based on a questionnaire, including 1598 patients with CD and a randomly selected 
control group of 1000 subjects. Study II and III are the clinical studies comprised of 150 
patients with CD and a control group comprising of 75 subjects.  
The first specific aim was to investigate how patients with CD perceived their oral health 
compared to control group (Study I). Secondly we wanted to find out in a clinical study if CD 
patients had a higher prevalence and risk for dental caries (Study II). The third aim was to 
investigate whether CD patients had a higher prevalence and severity of periodontal disease 
compared to controls without CD (Study III).   
The main findings of all these studies revealed that patients with CD perceived their oral 
health to be poor (Study 1). Patients who had undergone resective surgery had a significantly 
higher DMF-S score (Study II) and CD patients had significantly more dental plaque and 
gingival inflammation (Study III). There were more smokers in the CD group when 
compared to the controls (Study I, II & III). 
Furthermore, our results in Study I reported that CD patients had a greater need for dental 
treatment and there was a correlation between more severe forms of CD and oral health. This 
group also reported more mouth and tooth related problems. Study II, showed that men in the 
  
CD group had significantly more decayed teeth decayed surface and more dental plaque 
when compared to CD women. The results in Study III showed that the percentage of 
CAL≥3 was higher in patients than controls which indicates that they had a greater 
prevalence of periodontitis. No differences in radiographic bone loss was observed between 
CD patients and controls.  However, men in the CD group had significantly more BOP, 
CAL, alveolar bone loss and higher prevalence with periodontitis compared to women in the 
same group.  
In conclusion, the findings in this project indicate that CD patients and especially men had a 
poorer oral health, more caries, dental plaque, BOP and CAL. Thus, our finding confirmed 
our hypotheses. There is a need to develop an oral care program, which include the 
prevention of oral disease, support and motivation to take care of the oral hygiene, as well as 
smoking cessation.   
 
 
Keywords: Crohn´s disease, oral health, questionnaire, DMFT, DMFS, dental caries, dental 
plaque, sugar consumption, inflammation, BOP, periodontal disease, PPD, CAL, BOP, 
inflammation 
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1.1 PERIODONTAL DISEASE  
Periodontal disease gingivitis and periodontitis are some the most prevalent chronic 
inflammatory conditions causing severe major public health problems worldwide 1.  
1.1.1 Gingivitis 
Gingivitis  affects up to 90% of the population 2, being the first manifestation witch is an 
inflammation of gingival soft tissue predominantly initiated in response to pathogenic 
microflora in the dental plaque adherent to tooth surfaces. Clinical signs of gingivitis are 
characterized by swelling, bleeding and redness (Figure 1) 3, 4. Gingivitis can be reversed if 
the biofilm is disrupted and adequate plaque control maintained 5, 6 . However, if left, 
untreated gingivitis can progress to destructive chronic periodontitis, involving breakdown of 
the tooth-supporting structures 7.  
 
 
Figure 1. Gingivitis. Inflammation of gingival soft tissue,                                             
characterized by swelling, bleeding and redness.  
 
1.1.2 Periodontitis 
The prevalence of periodontal disease varies in different parts of the world from 13-57 % 
whereas severe periodontitis impacts about 5-20 % of population worldwide 8-15. 
Periodontitis is more advanced inflammation than gingivitis that is usually asymptomatic in 
the early phases and becomes uncomfortable and painful in periods when the disease 
progresses (Figure 2). 
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Periodontatis occurs when the inflammation extends into the tissue and leads to non-
reversible breakdown of the tooth supporting tissues, and alveolar bone loss 16-18. Finally, 
periodontitis left untreated, may lead to tooth loss and have an impact on quality of life 16-18 .  
 
 
Figure 2. Periodontitis. Advanced inflammation extend into the tissue. 
 
Some studies suggest that the surface area of inflammation in periodontal pockets may range 
from 8 to 20 cm² in moderate periodontitis and 50 to 72 cm² in severe peroidontitis. In 
subjects with no periodontitis the surface area of periodontal pockets accros all tooth has 
been suggested to be 5 cm² 19-21. Periodontitis is a multi-factorial disorder, which is 
influenced by genetic and environmental risk factors 1, 17, 22. Age, gender, and ethnicity are 
important non- modifiable factors for periodontitis, as well as the individual´s susceptibility 
22. However, possibly modifiable risk factors are social and behavioural factors, income, 
education status and smoking. Cigarette smoking is strongly associated with both prevalence 
and severity of periodontitis 22-25. It has been estimated that 75% of periodontal disease cases 
amongst current smokers were related to smoking and 50 % to former cigarette use 26. 
Furthermore, the associations between periodontitis and psychosocial stress have been 
proposed 27.  Behavioural factors are a key component to prevention of periodontal diseases 
enhancing the patient’s motivation, therefore motivational interviewing might be one 
appropriate methodology for this 5, 6. 
Associations have also been identified between periodontitis and systematic risk factors for 
example diabetes mellitus, obesity, hypertension, cardiovascular diseases and other chronic 
diseases characterised by underlying systemic inflammation 14, 27. 
Chronic periodontitis is diagnosed by clinical examination and study of x- images. The 
disease is divided into Localized periodontitis, when up to 30 % of teeth are affected and 
Generalized periodontitis, if more than 30 % of teeth are affected.  Severity of bone 
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destruction is divided in three classes based on the size of attachment loss: slight 1-2 mm; 
moderate 3-4 mm and sever ≥5 mm 28 . 
Periodontitis is an inflammatory disease and the pathogenesis complex involving interactions 
between bacterial products, host response, and inflammatory mediators, as well as 
environmental and genetic factors (Figure 3).   
 
 
Figure 3. Schematic model of pathogenesis of periodontitis.  PMNs- polymorphonuclears leukocytes; LPS- 
lipopolysaccharide; MMPs- matrix metalloproteinases. Adapted from Page and Korman 1997 29. 
 
There are over 700 bacterial species in the human oral cavity 30-32. It is known that microbes 
from the oral cavity can cause oral infectious diseases, including endodontic infections, 
tonsillitis, caries and periodontitis. A number of studies show evidence associating oral 
bacteria to systemic diseases, such as diabetes, pneumonia, cardiovascular disease 33-37. 
Periodontitis is initiated by the presence of bacteria on the tooth surface and in the gingival 
crevice 17. The process starts when bacterial species in oral cavity adhere to each other and 
form a microbial biofilm on the tooth surface, first supragingivally in the gingival crevice 
and later subgingivally, forming a gingival pocket (Figure 4) 38. Bacterial growth in the oral 
biofilm is influenced by the exchange of metabolites, chemical signals, and toxic products 
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that form a protective matrix helping to the development of periodontitis 39. Oral bacteria 
accumulated on the tooth is primarily Gram-positive and include species of Streptococcus 
and Actinomyces. 
 
 
 
Figure 4. Plaque begins to form in the gingival sulcus and other protected niches of the tooth. (a) Destruction 
of collagen will occur as a direct result of microbial action through their release of toxins, 
lipopolysaccharides or enzymes. (b) Bacterial plaque forms as a biofilm in the gingival sulcus shortly after 
the cleansing of the tooth surface. Three-day-old plaque.  
Reprinted with the permission from the publisher John Wiley & Sons 7. 
 
 
Subsequently this matrix adopts to a more anaerobic, Gram-negative environment, which 
accumulates deeper in gingival sulcus 38, 40. Periodontal pathogens, such as Prevotella 
intermedia, Aggregatibacter actinomycetemcomitans and the group named “red complex” 
including bacteria species Porphyromonas gingivalis, Treponema denticola and Tannerella 
forsythia that become more prevalent in deep periodontal pockets and significantly linked to 
advanced periodontitis. These microorganisms stimulate an inflammatory response which 
can cause destruction of periodontal tissues in susceptible individuals 41. Periodontal disease 
is not generally expressed in individuals with poor oral hygiene that harbor periodontal 
pathogens but the disease are also more involved in a susceptible host 42. 
Chronic periodontitis starts with an infection initiated by pathogenic bacteria from the oral 
biofilm. Microbial products, such as proteases, lipopolysaccarides (LPS), metabolic and 
other toxic product in sulcus attack the host defence mechanisms and modify immune 
responses. This microbial challenge induces a host -mediated tissue destructive immune 
response 43-45. The inflammatory responses activate immune cells such as neutrophils and 
a b 
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macrophages/monocytes, which are primary protective components of the first-line defence 
16, 44. 
In periodontitis the microbial challenge continues and LPS from Gram negative-bacteria 
stimulates inflammatory mediators e.g., macrophages/monocytes, neutrophils and T-
lymphocytes to produce proinflammatory cytokines including TNF-α (tumor necrosis factor- 
α), IL-1β (Interleukin-1β), IL-6 (interleukin-6), PGE2 (prostaglandin E2) and matrix 
metalloproteinases (MMPs), which play a significant role in the damage of tissue and 
periodontal bone resorption 16, 29, 44. Although, some of bacterial components can initiate 
periodontitis it is important to consider various risk factors such as cigarette smoking and 
heredity with outweigh the disease occurs and the severity of clinical outcome 22, 25. 
1.2 DENTAL CARIES 
Dental caries is a major public health problem worldwide in most industrialized countries 
and causes tooth pain and tooth loss. People are predisposed to this chronic disease thought 
their lifetime but studies show that caries progression slow down with increased age 46. In 
general caries, prevalence and severity has decreased in high-income countries over recent 
years 47, 48. However, in low-income countries dental caries continues to increase amongst 
people with low education and socioeconomic status, and absence of oral health care service, 
poor lifestyles and elderly 49-52.  
 
 
 
 
                      Figure 5. Factors that interact to form dental caries. Adapted from Krol 200351 
HOST FACTORS
CARIOGENIC 
BACTERIA
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Miller (1890) was the first to demonstrate the bacterial invasion of dentinal tubules of both 
carious and non-carious dentin association with lactobacilli-dentinal caries was reported by 
Goadby in 1899 53. However, it was not until the late 1950 s that experimental evidence 
clearly established the fundamental role of these bacteria in dental caries 54. They are now 
considered secondary invaders rather than initiators of the caries process 55.   
Established risk factors are now include increase of cariogenic bacteria, decreased salivary 
flow, insufficient oral hygiene, poor dietary habits such as increased sugar consumption, 
consumption of soft drinks, as well as socioeconomic factors 51, 56-59. Dental caries define 
both caries lesion and caries process 60, 61. Cavity, or decayed surface is a drastic result from 
interactions over time between bacteria, a substrate and host factors that include teeth and 
saliva (Figure 5) 51, 61. Dental caries is a multifactorial disease that starts with changes inside 
the biofilm/dental plaque and is affected by salivary flow and composition, exposure to 
fluoride, consumption of dietary sugars, and by preventive behaviors. A systematic review 
supports a relationship between the amount of sugars consume and dental caries 
development 62.  A 4-year prospective study, reported that consumption of sugar-sweetened 
beverages on a daily basis will lead to greater caries risk in adults and that such risk will 
increase even further with increasing frequency of daily consumption. An association was 
consistent across socio-demographic characteristics 63.  
Endogenous bacteria in the biofilm mostly Lactobacilli and Mutans streptococci, such as 
Streptococcus mutans and Streptococcus sobrinus produce acid a by- product of metabolism 
of fermentable carbohydrates 64. Streptococcus mutans exemplifies the cariogenic properties 
of sucrose metabolism, acidogenicity via fermentation, and adherence and biofilm formation 
via synthesis of extracellular glucans 65.  Studies have described the relationships between 
the rate of high intake of medication, subjective feeling of dry mouth, saliva flow, saliva 
composition and the salivary level of lactobacilli in adults. Clearly, lactobacilli play a 
significant role within the oral ecosystem whether oral health or carious diseases 66-69. 
Caries lesions develop when the acids as by-product from metabolism of fermentable 
carbohydrates, causes the local pH value to decrease below a critical value resulting in 
demineralization and destruction of hard tooth tissues. If the diffusion of calcium, phosphate 
and carbonate out of the tooth is allowed to continue, cavitation will eventually take place. 
Caries demineralization can be reversed and stopped in its initial phases through uptake of 
fluoride which supports the circulation of calcium and phosphate into the tooth, allowing 
remineralisation of the crystalline structures in the lesion and rebuild surfaces of fluoridated 
hydroxyapatite and fluorapatite. Saliva acts as a buffer and restores pH in the biofilm.  If 
dental caries stops, progresses or reverses over time is dependent on the balance between 
demineralization and remineralisation and without proper oral hygiene can develop, spread 
into the dental pulp and destroy the tooth 70, 71. 
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        Figure 6. Schematic model of approximal caries. a- pulp; b-dentin; c- enamel. 
 
The caries disease can be seen on both the crown and root and it can affect enamel, dentin 
and cementum. Caries diagnosis includes visual and tactile examination with a dental probe, 
and detection of lesions on approximal surfaces with bitewings radiographs 72, 73. 
Approximal caries categorized as enamel caries D1, D2 and D3 as dentin caries (Figure 6). 
Dental caries experience indices in: tooth DMFT index (number of Decayed, Missing due to 
caries, and Filled Teeth in the permanent dentition) and surface levels DMFS index (number 
of Decayed, Missing due to caries, and Filled Surfaces in the permanent dentition). DMFT is 
divided into very low <5.0; low 5.0-8.9; moderate 9.0-13.9; high >13.9. DMFS 74, 75.  
1.3 CROHN´S DISEASE 
Inflammatory bowel diseases (IBD) are significant health problems worldwide that cover a 
variety of overlying clinical diseases characterized by chronic inflammation at different sites 
in the gastrointestinal tract. IBD, include collagenous, eosinophilic, lymphocytic and 
indeterminate colitis but most commonly are ulcerative colitis (UC) and Crohn´s disease 
(CD). UC causes inflammation in the large intestine and rectum, whereas CD can affect the 
whole gastrointestinal tract although mainly the large intestine, small intestine or both 76, 77. 
CD was described in 1932 by American gastroenterologists, Burrill Bernard Crohn, Leon 
Ginzburg and Gordon D. Oppenheimer and since that time, the name of the disease has been 
connected with Dr. Crohn´s name and used in the literature. The author of the first Polish 
description of the disorder from 1904 was surgeon Prof. Antoni Leśniowski and  in Poland 
the disease is known as Leśniowski-Crohn’s disease out of the respect for this author´s 
contribution 78, 79. 
D1 D2 D3
 
a 
b 
c 
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The prevalence and incidence of CD varies around the world, with the highest rates in 
developed countries. CD is most common in Northern Europe and North America 80-84. In 
Sweden, the prevalence is about 2 % and 5 to 7 individuals per 100,000 are diagnosed with 
CD every year 85-88. The highest reported incidence of CD in Europe was 12.7 per 100,000 
person and 20.2 per 100,000 person- a year in North America. The highest reported 
prevalence values for CD in Europe were 322 per 100,000 persons and North America 319 
per 100,000 persons 80. The incidence and prevalence of CD increases in the world both in 
industrialized and developing countries, and the disease seems to be emerging as a global 
disease 80, 81. CD can occur at any time from childhood to late adulthood and both gender are 
likewise affected. This disorder is most commonly diagnosed before the age 40 but the 
numbers being diagnosed during their late teens and twenties is increasing 83, 89-91.  
CD is characterized by episodes or flares with symptoms alternating with symptom-free 
phases, remissions. Typical symptoms during flares are abdominal pain, fatigue, fever and 
bowel obstruction with diarrhoea and rectal bleeding, significantly impairing quality of life 
76, 92, 93. Diagnosis of CD is based on history, clinical examination, endoscopy with biopsies 
and complementary histological, radiographic and laboratory findings 93, 94. It has been 
suggested that CD starts as an inflammatory process and might develops over time to a more 
complex disease with stricture, fistula and abscess formation 92, 95, 96. 
At present, CD therapies are aimed to reduce the inflammation during a flare, i.e. induce 
remission, and to prevent a new flare, i.e. maintain remission and progress of the most 
common symptoms, mainly abdominal pain. There are several pharmacological alternatives 
such as glucocorticosteroids, immunomodulators and biological agents. For some patients, 
for whom pharmacotherapy is inappropriate, or those not responding to pharmacotherapy 
surgical treatment is appropriate 93, 97-99. Until recently, there has been no curative medication 
for CD and the drugs also cause several side effects. Surgery does not cure CD but in some 
circumstances it can be considered as a possible alternative to pharmacotherapy. Indications 
for surgery, include complex abscesses and fistulas, strictures with symptoms of bowel 
obstruction and cancer 100. About 50 % of patients with CD have intestinal complication after 
diagnosis and need surgical treatment 101. At 10 years follow up after resection of intestine 
has shown that about 30% to 50% of the patients require surgery, - or needed 
supplementary surgical treatment 90, 101-103. 
Oral findings associated with CD were first described by Dyer et al. in 1969 104. Specific oral 
manifestations related to CD include frequent ulcerations, aphthous stomatitis, fissures, 
diffuse face- and lips erythema and hyperplasia in the mucosa. Hyperplasia is often found in 
combination with fistula and granuloma formation, which have the same histological form in 
the gastrointestinal tract. The frequency of oral manifestations in CD patients has varied 
between 0.5- 20% 105, 106. Oral manifestations could be the first clinical feature of IBD. In 
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some individuals the oral manifestations occurred up to 10 years prior to presentation in the 
gastrointestinal tract 107-110.  
The aetiology of CD is poorly understood but an interaction between genetic, microbial and 
environmental factors may participate in the development and progression of CD 77, 111-113. A 
growing number of studies suggest the involvement of several genes in CD and IBD 
development but the contributions of genetic factors are complex 114, 115. Some studies with 
monozygotic twins suggest hereditary for CD of between 20 to 50% 116-118.  Genetic factors 
are known to regulate the structure of the microflora 119 and in addition, a link between the 
microbiota and the lining of the gut mucosa has been proposed as possible aetiological 
environmental factors 111. Several theories, mostly related to urban living, are possible, such 
as consumption of a Western civilization diet containing large amounts of refined sugar and 
dietary fats 113, 120-122  as well as stress 123, 124. Hygiene hypotheses indicate that reducing 
microbiological variation and rising incidences of autoimmune disease 125. Smoking worsens 
CD, reducing treatment responses and increasing the number of relapses and complications 
126, 127. However, the specific cause of the disease mains to be fully clarified 128. 
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2 AIMS OF THE THESIS 
  
  
14 
 
  
  
 15 
2.1 GENERAL OBJECTIVES  
The general aim of this project was to test the hypothesis that patients with Crohn´s disease 
(CD) have worse oral health than people without CD. In the future the project also aims to 
provide new opportunities for support strategies for the prevention of oral disease in these 
patients who already suffer from a lifelong disease.   
2.2 SPECIFIC OBJECTIVES  
2.2.1 Study I 
The aim of was to investigate perceived oral health of patients with CD in comparison with a 
control group with no CD in Sweden.  
2.2.2 Study II 
The aim was to test the hypothesis that patients with CD have a higher prevalence and risk 
for caries compared to people without CD.  
2.2.3 Study III 
The aim was to test the hypothesis that patients with CD have higher prevalence and severity 
of periodontal disease compared with controls without CD. 
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3 MATERIAL AND METHODS 
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3.1 ETHICAL CONSIDERATION 
The research project conformed to the ethical principles for medical research in humans 
according to the recommendations of the Declaration of Helsinki. All subjects gave their 
written informed consent to participate. Study I did not need ethical approval in 2006. Studies 
II and III were approved by the Karolinska Institutet Ethical Research Board in Stockholm, 
Sweden, ref.nr. 2007/ 2:11, 2009/ 1953-32. 
3.2 STUDY POPULATION 
 
Figure 7.  Flow-chart showing the selection of subjects from 2006 to 2010. Questionnaire from 2006-2007 was 
analysed and described in Study I. The clinical examination and questionnaire from 2008-2010 were analysed 
and descried in Studies II and III.  
 
3.2.1 Study Population, Study I 
3.2.1.1 Patients 
A questionnaire was sent between autumn 2006 and spring 2007 to all members of Swedish 
Association of People with Stomach and Bowel Diseases with the diagnosis Crohn´s disease 
(CD). Totally, were 1943 questionnaires were sent to the patients and 1598 of them were 
returned. 68 % were women and 32% men, mean age 49. 7 years, who responded the 
questionnaire (Figure 7). 
2006-
2007
Questionnaire 
(n=2943)
Patients 
(n=1943)
Participate 
(n=1598)
Controls 
(n=1000) 
Participate 
(n=748)
Study
I
(n=2346)
2008-
2010
Clinical examination
Questionnaire
(n=490)
Patients 
(n=309)
Participate 
(n=150)
Study
II & III
(n=225)
Controls 
(n=181)
Participate 
(n=75)
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3.2.1.2 Controls 
A randomly selected control group with 1000 subjects was chosen through National 
Statistics Organization in Sweden, SCB. The control group was matched to get the same age 
and gender as in CD group. 748 subjects who answered the questionnaires and 67 % of them 
were women and 33 % were men. The mean age of the controls was 49. 5 years.  
The number of patients included was provided by the number of members in the patient 
organization who were diagnosed with the CD. 1000 controls were chosen to allow for an 
observed difference in perceived oral health of 10% with a power of over 90%. 
3.2.1.3 Non-responders 
345 CD patients and 252 controls without CD, of all subjects invited to participate in study 
declined and the reason was not asked.  
3.2.2 Study population, Study II and III 
3.2.2.1 Patients 
Patients with diagnosis of CD, attending the outpatient clinic at the Department of 
Gastroenterology and Hepatology at Karolinska Hospital in Huddinge, between September 
2008 and June 2010, were invited to participate in the study.  309 patients were asked to 
participate and 150 patients were enrolled, 73 females and 77 males, aged 18–77 years 
(Figure 7). 
3.2.2.2 Controls 
The control group was selected from 181 individuals that were randomly recruited through 
National Statistics Organization (SCB) in Sweden. 75 persons, 45 females and 30 males, 
accepted to participate in the study, aged 18–74 years. Selection of the control group was 
structured to achieve the same age and gender distribution as the patient group. All subjects 
were living in Huddinge community of Stockholm. 
The number of CD patients (n =150) and the controls (n =75) was chosen to observe 10% 
differences of the population with a power of over 90%. Smaller differences were not 
clinically relevant. The power calculation was based on the differences reported by Brito et 
al. 2008 129. 150 CD patients and 75 controls would provide 80% power to detect a 
difference in means of DMFT of 2.8 between the groups (22%). The common standard 
deviation was 7.0, with a 0.05 two-sided significance level. 
3.2.2.3 Non-responders  
159 patients in the CD group and 106 individuals in the control group declined to participate 
in the study, though the reason was not asked.  There was no statistical significance between 
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age and gender of the participants and those who did not participate by a comparative 
analysis.  
3.3 QUESTIONNAIRE 
3.3.1 Questionnaire, Study I 
The questionnaire and two reminders were sent by mail to both groups. The questionnaire 
was also available on the internet. Questionnaires to the patient and control groups were 
identical except for the questions about CD.  The questionnaire contained 36 questions, 
including questions about socio-economy, dental care habits, oral health, general health and 
tobacco use. Most questions in the study were of the multiple-choice type. 
The CD patients were asked to estimate the severity of their bowel disease from 1 to 10. 
Both groups were asked to estimate their oral health as compared to others at the same age. 
The alternatives offered were “Much better”, “Similar, “Worse”, “Much worse” or “Don’t 
know”. Similarly, they were asked to estimate their need for dental care with the alternatives 
“Very large”, “Large”, “Moderate”, “Small” and “Don’t know”. The question “Does your 
gingiva bleed?” had three response alternatives, “Yes”, ”Yes, but only when I brush my 
teeth”, and ”No”. The two yes responses were collapsed into one “yes answer”. The 
participants were also asked if they had periodontitis and were given three alternatives, 
“Yes”, “No” or “Don’t know”. The questionnaire also include questions about smoking 
habits and if they had been former smokers, and smoking was quantified by the number of 
cigarettes smoked per day. The CD patients were asked if they had changed their diet when 
they got CD, the alternatives were “No”, “Yes, I eat more often” and “Other changes”, with 
an opportunity to explain those changes.  
3.3.2 Questionnaire, Study II and III 
All participants completed a questionnaire that covered demographic data, including age, 
gender, income, education level, medical history, medications, and smoking habits. Most of 
the questions in the questionnaire were of the multiple-chose type. Several questions were 
based on the questionnaire from Study I. Smoking habits were reported as current smokers, 
former-smokers and never smokers, the response alternatives were yes or no. Questions 
concerning oral hygiene practice, included frequency of tooth brushing, interproximal 
cleaning, and visits to the dentist and/or dental hygienist. The questionnaire included 
questions cornering dental health, if during the last 12 months there had reported any 
toothache, dry mouth and bad breath, and if they had any problems with oral ulcerations. The 
response alternatives to these questions were yes or no. In addition, all participants were 
asked about eating habits, including frequency of meals and consumption of sweetened 
drinks between meals. The patients with CD were also asked how long they have had their 
disease, and if they had undergone any surgical procedure.  
  
22 
3.4 SAMPLING AND SALIVA ANALYSIS 
3.4.1 Saliva Sampling   
Subjects were  instructed to not to eat, drink, smoke or brush their teeth one hour before 
sampling to avoid contamination of the oral cavity as a result of food intake or smoking. 
Before the clinical examination, unstimulated whole saliva and saliva stimulated by chewing 
paraffin wax was collected during a five minute period. Salivary flow rates were measured in 
milliliters per minute immediately after collection.  
3.4.2 Analyzes of Lactobacilli and Mutans streptococci  
Mutans streptococci (SM) counts were measured with Dentocult ® SM Strip Mutans, Orion 
Diagnostica. Bacitracin disc was place in the selective culture broth 15 minutes before 
samplings. The patients were instructed to chew a paraffin pellet for one minute before 
swallowing and the strip was pressed on patients tongue and removed through gently closed 
lips. The strip with saliva was attached to the cup and incubated at 35 to 37° C. The cup was 
open one quarter of a turn. After 48 to 96 hours the bacteria density on the strip was 
compared to the model chart (Figure 8). Salivary Lactobacillus (LB) counts were measured 
using Dentocult ® LB, Orion Diagnostica. The tube with stimulated saliva over both agar 
surfaces was incubated for four days in 36 ± 2 °C. The colony density was compared with 
the model chart, after the incubation (Figure 9). The salivary level of Mutans streptococci 
and Lactobacilli was measured according to the manufacturer´s instruction and expressed as 
colony-forming units/millilitre saliva (CFU/ml).  
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                 0                          1                        2                        3 
Class 0= <10 000 CFU/ml; Class 1= <100 000 CFU/ml; Class 2= 100 000 – 1 000 000 CFU/ml, Class   3= >1 000 000 
CFU/ml 
Figure 8. Model chart.  Mutans Streptococci growth expressed as bacteria colony-forming units/milliliter saliva 
(CFU/ml). High number class 2 and class 3. Adapted from Dentocult ® SM Strip mutans, Orion Diagnostika 
OY. 
 
    
             10³                       104                        105                        106 
Figure 9. Model chart. Lactobacilli growth, expressed as bacteria colony-forming units/milliliter saliva    
(CFU/ml).  Low numbers <1 000 CFU/ml saliva. High numbers >10 000 CFU/ml saliva. Adapted from 
Dentocult ® SM Strip mutans, Orion Diagnostika OY. 
 
3.5 ASSESMENT OF ORAL HEALTH 
3.5.1 Clinical Examination 
Two investigators (SS/193 subjects, NR/32 subjects) made the oral and the radiographic 
examination of the participants in Study II and Study III. Prior to the clinical examination, an 
inter and intra operator calibration between the two examiners was conducted. Three 
participants from CD group were examined by both investigators to reach an agreement. In 
addition, repeated measurements within two patients were done by the same examiners. The 
clinical examinations were conducted after saliva sampling, registration of the number of 
remaining teeth and assessment of Visible Plaque Index, (VPI)130 at six sites on all present 
teeth, excluding third molars. 
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3.5.2 Examination of Dental Caries 
Caries Registration in Study II was assessed by WHO 131 methods and expressed by decayed, 
missing, or filled tooth (DMF-T) and surface index (DMF-S) in each person. The diagnosis 
was based on a clinical inspection, visually and tactically with an examination probe and 
following bitewing x-rays. Clinically, caries was recorded when a lesion had a cavity, 
undermined enamel or an obviously softened surface, or the probe became stuck by using 
light pressure. Filled surfaces with caries were registered as both decayed and filled.  
3.5.2.1 The radiographic examination 
The radiographic examination was done with bitewing radiographs. All tooth surfaces that 
could not be evaluated clinically were evaluated by the radiographs. Dental caries on the 
radiographs was recorded if the lesion reached the dentin. The examiner of the radiographic 
images was blinded, an intra-examiner measurement analysis was performed in 10% of the 
randomly selected patients and controls, with the measurements reaching identical results in 
89% of the cases. 
3.5.3 Examination of Periodontal Disease 
Periodontal examination in Study III included registration of bleeding on probing (BOP)132, 
probing pocket depth (PPD) and clinical attachment level (CAL) on six sites on all present 
teeth, excluding third molars, using a periodontal probe (Hu-Friedys® PCPUNC 15, 
Chicago, IL, USA). The presence of periodontitis was defined as having mean CAL ≥ 3mm 
at all sites.  
3.5.3.1 The radiographic examination 
The radiographic examination comprised of four bite-wing radiographs. Alveolar bone loss 
on the x-ray was gauged in pixel, from the mesial surface of second molars to the distal 
surface of canine teeth. Alveolar bone loss was measured from the cemento-enamel junction 
(CEJ) to the most apical part of the alveolar bone. Teeth with indistinct CEJ were excluded. 
The alveolar bone level on the radiographic images was studied by one examiner, who was 
calibrated and blinded the test and control group. 
3.6 DATA ANALYSIS 
3.6.1 Study I 
Odds ratios (ORs) were calculated with a multiple logistic regression adjusting for age, 
smoking, gender and education. The significance of the differences between groups was 
calculated with Chi-Square, Students unpaired t test or Mann-Whitney U test. Correlation 
between severity of CD, oral health and dental care needs was calculated with Spearman 
partial correlation, adjusting for age and smoking (Table 1).  
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3.6.2 Study II 
Data analyzes were performed using the software package PASW Statistics 18 (PASW Inc., 
Chicago, IL, USA). Significance of the demographic differences between patients and 
controls were calculated with ANOVA and variables with only two factors were calculated 
with Chi-square test. Post hoc analyzes were done with Fischers Least Significant Difference 
test or Chi-square. Analysis of covariance (ANCOVA) to control for age, gender and 
smoking were performed to compare the clinical variables between the groups, post hoc 
analyzes were done with Fishers Least Significant Difference test (Table 1). P-values of 0.05 
or below were considered significant. Non-parametric data were normalized with a 
logarithmation. Non-parametric Spearman’s correlation matrix coefficient was estimated 
between clinical variables and disease duration. 
3.6.3 Study III 
The significance/P-values of differences between CD patients and controls were calculated 
with Students independent samples t-test for age and number of missing teeth. For all other 
variables Pearson Chi-Square test were used. Statistical comparisons used a General Linear 
Model with group, gender and smoking as factors and age as a covariate, (Table 1). Analyzes 
were performed using the software package PASW Statistics 18 (PASW Inc., Chicago, IL, 
USA). 
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4.1 STUDY I 
Patients with CD in estimated their oral health to be poorer compared to others in the same 
age group, with en OR of 9.7 (95% CI, 5.8 to 16.4). CD patients reported a greater need for 
dental treatment than the controls, with an OR of 5.7 (95% CI, 4.2 to 7.9) after adjustment 
for age, smoking, gender and education.  We found also a correlation between the more 
severe forms of CD and oral health (R=0.31, p<0.001) and more dental care needs (R=0.31, 
p<0.001) after adjusting for age and smoking. CD patients reported significantly more mouth 
and tooth related problem such as tooth toothache, caries, gingival bleeding and ulcerations, 
lost or broken filling, broken crown and bridge work, halitosis and mouth dryness, compared 
to the persons without CD (OR 3.2, 95% CI 2.5 to 4.0). 96% of participants brushed their 
teeth twice daily or more. CD patients visited a dentist or dental hygienist significantly more 
often than persons without CD (p<0.001). Approximately 50 % of the participants visited 
dental clinics once a year. 11% percent of the patients and 2 % of the controls visited dental 
clinics more than twice a year (OR 8.7). Moreover, significantly more CD patients reported 
that they took some kind of medication (89% versus 37%, p<0.001), reported significantly 
more bleeding in the gingiva (p<0.001) and suffered with periodontitis (p<0.028) than 
controls. There were significantly more smokers in the patient group (p<0.001). 
4.2 STUDY II 
We found significantly a higher DMF-S score (decayed, missing, filled surface index) in CD 
patients who had undergone resective surgery (RS) (50.7 versus 36.5, p=0.01) compared to 
the control group after adjusting for age, gender and smoking. The result in RS group 
showed a weak positive correlation between disease duration and DMF-S (r=0.374; p=0.01), 
FS (r =0.424, p=0.001) and MS (r=0.272, p=0.005). These correlation was not found in the 
NRS group. The RS group also showed a higher DMF-T index (decayed, missing, filled 
tooth index) but the difference did not reach statistical significance (p= 0.06). Our analyzes 
demonstrated that men in the CD group had significantly more decayed teeth (DT) (2.5±3.7 
versus 1.5±2.1; p =0.05), decayed surfaces (DS) (4.3±8.6 versus 2.1±4.1; p= 0.05) and more 
dental plaque were compared to CD women (56.4±27.1 vs. 42.4±26.1; p= 0.005).  No gender 
differences were observed in the control group. CD patients shown significantly higher level 
of LB and amounts of dental plaque and RS group had more SM compared to the control 
group. Oral hygiene habits and frequency of meals did not differ between the groups. 
However CD patients reported significantly more frequent intake of soft drinks between the 
meals (p=0.001). 
4.3 STUDY III 
CD patients were shown to have significantly more BOP (50.8±25.0 versus 25.4±19.7; 
p<0.001), CAL (2.2±1.1 versus 1.4±1.2; p<0.001), VPI (48.9±27.6 versus 22.1±20.4; 
p<0.001) than subjects without CD, adjusting for age and smoking. Periodontitis, where 
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measuring as the percentage of CAL≥3 was also higher in patients than controls (22.7% 
versus 5.4%; p<0.001) adjusting for age and smoking. 83.9% of the patients with CD and 
31.9% of the controls took medication regularly (p<0.001). 47 % of CD patients had 
undergone surgical treatment and 74 % had used some pharmacotherapy for CD. There were 
significantly more smokers in CD group than in control group (21.8% versus 6.7%; 
p=0.004). Men in the patients group had significantly more of dental plaque, VPI 
(56.1%±27.7 versus 42.9%±25.7; p=002), gingival inflammation, BOP (57.7%±24.4 versus 
44.3%±23.8; p=0.003), CAL (2.5mm±1.2 versus 1.9±0.9mm; p=0.005), PPD (2.1mm±0.5 
versus 1.9mm±0.4; p=0.036) , periodontitis (30.1% versus 15.6%; p=0.033) and more 
alveolar  bone level loss (45.4pixel±19.6 versus 37.5pixel±11.8; p=0.032) compared to 
women  in the same group adjusting for age and smoking.  
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5 SHORT SUMMARY AND DISCUSSION 
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This research was initiated by the Swedish Association of People with Stomach and Bowel 
Diseases (RMT) and Department of Gastroenterology and Hepatology, Karolinska 
University Hospital, Huddinge. Both of these institutions had received questions from CD 
patients regarding their poor oral health and that oral health problems had increased amongst 
their members. To date, few studies exist investigating the effect of CD on oral health. Since 
CD may have an impact on both dental caries and periodontal diseases, it was important to 
further investigate these associations 
5.1 STUDY I 
In Study I we used a questionnaire to investigate how patients with CD perceived their oral 
health. The results showed that CD patients perceived their oral health to be worse and 
reported a greater need for dental treatment than a control group of the same age. Our result 
also showed a correlation between the more severe forms of CD and oral health and more 
need of dental care. Furthermore, CD patients reported significantly more mouth and teeth 
related problems such as toothache, caries, gingival bleeding and ulcerations, lost or broken 
fillings, broken crown and bridge work, halitosis and mouth dryness, compared to persons 
without CD. Dental problems such as tooth caries, oral ulcers and dry were significantly 
more frequent in the CD patients than in healthy controls 133. 
Earlier studies have investigated relative small sized groups and shown a higher prevalence 
and higher caries risk in CD patients compared to healthy controls 134-137. Though, our study 
was based on a questionnaire it showed the same pattern regarding their oral health situation. 
Another study reported that patients with inflammatory bowel disease (IBD) had 
significantly more dentin caries than controls, but in that study patients with both CD and 
ulcerative colitis (UC) participated 138. The oral condition in CD patients may be explained 
by changes in dietary habits and a higher intake of medicine. It is known that CD patients are 
recommended to eat more frequently in order to reduce pain and diarrhoea that could lead to 
increased dental caries, which has been correlated to dietary habits, like higher sugar intake 
and insufficient oral hygiene habits 136. Our patients reported that they ate significantly more 
often during the day and had changed to a fat reduced diet, which may contain more 
carbohydrates, thus leading to an increased risk for caries. A questionnaire study by Russel et 
al. showed a positive correlation with cola drinks and the development in CD 139. Moreover, 
significantly more patients in the present study reported that they were taking some kind of 
medication (89%) as compared to the controls (37%). Use of medication primarily the 
corticosteroids could be a reason to reduced saliva production.  Dry mouth is another factor 
which can also contribute to increased caries risk since saliva is important for the 
remineralisation of the enamel 140.  
Almost all participants, 96 %, in this study brushed their teeth twice daily or more, which 
could reflect the preventive strategies during the last 30-40 years in Sweden. A study from 
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US reported a significant higher frequency of tooth brushing, using dental floss and mouth 
fresheners at the disease onset in patients with CD compared to controls 133, while another 
study found no association regarding frequency of tooth brushing 139. In our study we didn´t 
investigate use of flossing or use of breath freshener. Furthermore, visits to a dentist or dental 
hygienist were significantly more common in our patient group which also suggests that they 
are more in need of dental care. This is in similar to Singhal et al 133.  
In this study patients reported significantly more bleeding from the gums and presented with 
more periodontitis than controls.  Higher degree of periodontitis could be explained by the 
fact that there were significantly more smokers in the patient group. Smoking tended to 
develop a more severe form of CD, and have also a detrimental effect of the outcome of CD 
141. It is well-known that smoking is one of the most important risk-factors for both CD and 
periodontitis 24, 142. Gingival bleeding has previously been reported in patients with active 
CD 143.  Earlier studies have described a tendency of more CAL in patients with IBD and a 
higher prevalence of periodontitis compared to the general adult population in the United 
States 138, 144. In general, reports relating IBD and particularly CD to periodontal disease are 
few and evidence for an association between the two diseases is lacking 138, 144-146.   
A strength of the present study is the low dropout rate out of the 1943 patients with CD, 
where 1598 (88%) answered the questionnaire and out of the 1000 controls, 748 (75 %) 
responded. Conversely a limitation could be that it is a questionnaire study and dependent 
upon self-reported oral health, therefore, less valid than findings from clinical examinations. 
Nonetheless, self-reported observations can be regarded as adequate for considering the 
relationship between perceived, real -data and general health. Another study found good 
consistency between self-reported and clinical observations 147.  
The findings in Study 1 reported that CD patients perceived worse oral status that a control 
group and clinical studies are needed to confirm this relationship 
5.2 STUDY II 
In this study, we clinically examined CD patients and controls and we found a significantly 
higher number DMF-S scores in those CD patients who had undergone RS compared to the 
control group. The RS group showed also a higher DMF-T but the difference was not 
statistically significant. These results also support our findings from the questionnaire study 
(Study I). Other researchers have found significantly higher DMF-T in CD patents 129, 134-136, 
however they did not differ between the CD patients into surgical and non-surgical groups.  
On the other hand, Grössner-Schreiber et al. (2006) found no significances in DMF-S but 
reported significantly more dentin caries and plaque in patients with IBD, which include both 
CD and ulcerative colitis 138. One explanation for the different results between the two CD 
groups might be that the patients, who had undergone surgery, had a more severe form of the 
disease. A recent study by Karczewski et al. (2014) reported that CD patients who smoked 
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had more frequently undergone surgery, and thus suffered from a more severe form of the 
disease and also required immunosuppressive therapy more often. Probably, there are several 
risk factors which are involved in the disease which may have an impact on oral health, and 
since smoking is one of the most important risk factors also for periodontal disease we found 
it important to divide the CD patients into a surgery and non-surgery group 141.   
There was also a weak correlation between DMFs and disease duration in the surgery group, 
which was not found in the non-surgery group. The results from Study 1 also supports this 
data where more severe forms of CD were associated with decreased oral hygiene.  It could 
also be speculated that over the years of suffering from the disease prior to the RS the 
patients experienced problems with their oral health status and many caries restorations were 
performed. The most interesting findings from Study II is illustrated by the gender 
differences. Our analyzes revealed that men in the CD group had significantly more caries 
and more amounts of plaque compared to women. The reason for this is difficult to explain 
but one speculation might be that men in the CD group had worse oral hygiene habits, less 
frequently dental visits or worse dietary habits 148. This speculation may be confirmed when 
analyzing the results in Study I from a gender perspective. In the present thesis, this has not 
yet been performed but is one of our planned future studies.  
CD patients in this study had significantly more dental plaque compared with a controls, 
which could have an impact on caries development and is in accordance with earlier studies 
138, 149.  The results also showed that oral hygiene habits and frequency of visits to the dentist 
and dental hygienist did not differ between the two groups. CD in general had higher levels 
of Lactobacilli (LB) in saliva and the RS group had also significantly higher salivary counts 
of Streptococcus mutans (SM) compared to the control group. Other studies have confirmed 
that patients with CD had higher numbers of these cariogenic bacteria which involved in 
caries activity but species differences exist 137, 150, 151.  
Prevalence of caries in patients with CD could be enhanced by dietary habits. Sugar 
consumption could be the main reason of higher prevalence of caries in CD patients. Studies 
showing that patients consumed larger amounts of highly refined carbohydrates are 
associated with increased caries risk 136, 149, 152, 153. CD patients in our study reported more 
frequent consumption of sweetened drinks between meals compared to controls and more 
dry mouth. Eating habits differed from the questionnaire study (Study 1) which reported that 
CD patients ate significantly more frequently than the control group. It should also be 
noticed that 44% of the CD patients reported that their oral hygiene had failed after they 
were diagnosed (Study I).  
Our results confirmed that caries is a multifactorial disease and involve many risk 
factors.Further studies should focus on developing individual caries preventive programmes 
for CD patients. This knowledge is important since both the dental and the medical care 
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should be aware of and informed the patients about this risk. Since many areas face the same 
risk factors, collaboration with other health care professionals could be a possible way 154.  
5.3 STUDY III 
In Study III, we investigated periodontal clinical features of CD patients and compared them 
with a control group. Patients with CD had significantly more BOP, CAL and periodontitis 
than subjects without CD. The amount of dental plaque was also significantly higher in the 
patients group than control group.  
High scores for plaque and gingivitis in IBD and CD patients have been reported in earlier 
studies 138, 143, 149, 155. Plaque-induced gingivitis is the most common form of periodontal 
disease. The high gingivitis scores in our study corresponded to increased amounts of plaque, 
indicating poor oral hygiene in the CD group. This was also shown in Study I, where the 
patients reported more gingival bleeding compared to controls. As long as we do not know 
which individual that may develop periodontitis, gingivitis should be prevented and treated. 
Lang et al (2009) showed that an established gingival inflammation represents a risk factor 
for periodontal attachment loss and for tooth loss 7. In the present study, there were no 
differences regarding oral hygiene habits between the two groups according to the 
questionnaire, similar pattern was found in Study I. Another explanation could be that CD 
patients had more dental plaque as a result of more frequently eating and high consumption 
of sweetened drinks 136, 152, 156, 157. Additionally, CD patients may brush their teeth less 
effectively due to painful oral manifestations and or gingival bleeding during teeth brushing.  
The prevalence of oral manifestation in CD patients varies between 0.5 % and 20 % 105.  The 
patients in Study I reported higher score for ulcers, which also was confirmed in the clinical 
study 157.   
The strength of this study is the large size cohort of 225 people, including 125 patients with 
CD and 75 controls, who were clinically examined. However, it also need to consider the 
high number of drop-outs from the study, but there was no significant differences regarding 
age and gender. Another limitation could be that periodontal examinations were performed 
by two examiners, however, inter and intra calibration between the two investigators were 
conducted before the examinations. Furthermore, to the best of our knowledge this study is 
the first to measure alveolar bone level on the radiographic image.  However, the 
radiographic examination showed no differences in bone level between the two groups. A 
possible explanation could be that the radiographic measurements in our study were at two 
sites and measurement of CAL was at six sites on the teeth. CD patients in the present study 
had a higher prevalence of periodontitis, which are in agreement to Brito et al. 129. Also, in 
Study I the patients reported more problems with periodontitis than controls, however the 
difference was negligible after adjusting for age and smoking habits. PPD and CAL in our 
CD group was almost in line with other studies 129, 144. Furthermore, the prevalence of 
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periodontitis was increased but the severity was relatively small in the CD group, which is 
also in agreement with previous studies 129, 138, 144, 158 and does not have any major clinical 
implications. To note in our study, there were the fact that there are significantly more 
smokers in the CD group than in the control group although smoking is strongly associated 
with multifactorial chronic inflammatory conditions as periodontitis and CD 24, 127. A meta-
analysis found that current smoking was associated with an increased risk for CD (OR 1.76, 
95% CI= 1.40-2.22)159. From a clinical point of view it is obvious that tobacco cessation 
plays an important role and has an impact on the severity of these two chronic diseases.      
The present study also considered the gender perspective on all periodontal features in CD 
patients.  Men in the patient group had significantly more dental plaque, gingival 
inflammation, CAL, PPD, periodontitis and more alveolar bone level loss compared to 
women in the same group. This was in accordance with Study II, where men with CD had 
worse clinical status, decayed teeth compared to women. Other studies have also confirmed 
this and found more gingival inflammation in men with CD 136, 148.  
CD patients in this study have significantly more gingivitis and CAL but not more PPD and 
not more bone loss than patients in the control group. The reason for this could be that 
patients consumed more medication in general and immunomodulators in particular. On the 
other hand  a recent study by, Schulz et al reported that medication had no influence on 
periodontal status but found that patients who took aminosalicylates exhibited decreased 
bleeding and probing 136. In the present study, 84.0% of the patients with CD and 32% of the 
controls took medication regularly. The corresponding number of medication in Study I was 
89% in the CD group and 37% in the controls. 47 % of CD patients had undergone surgical 
treatment and 74 % had used some pharmacotherapy for CD. Duration of CD, number of 
intestinal surgeries and use of medication did not show any influence on periodontal status 
for this population group but this association is complex and needs to be further investigated. 
Interestingly, a recent review of O´Sullivan (2015), showed that vitamin D has emerged as a 
candidate of interest as an adjunctive treatment in CD 160. Intervention studies have 
suggested that vitamin D supplementation may reduce markers of disease activity in CD. 
Several strands of evidence suggest vitamin D as a potential anti-inflammatory therapy for 
conditions, such as IBD. The mechanism remains still unclear and needs to be investigated. 
The role of vitamin D in the periodontium has also been investigated and studies suggest that 
vitamin D and/or calcium intake results in reduced alveolar bone loss, gingival inﬂammation 
and/or attachment loss 161, 162.  
Finally our results combined with others conclude that patients with CD, especially men, 
have suboptimal oral hygiene and poorer periodontal status than persons without CD, 
suggesting the need for increased prophylactic efforts for this group of chronically ill 
patients.  
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6 CONCLUSIONS  
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 Patients with CD perceived a poorer oral health status, more tooth-related problems and 
greater need for dental treatment than subjects without CD (Study I). 
 
 CD patients who had undergone RS had higher numbers of DMF-S score and salivary 
counts of Lactobacilli and Streptococcus mutans than the control group (Study II). 
 
 CD patients have poorer periodontal status with more gingivitis, periodontitis and higher 
plaque score compared to people without CD (Study III). 
 
 Men with CD had diminished oral health with more plaque, caries and more severe 
periodontal disease compared to women with CD (Study II & III). 
 
 There were higher numbers of smokers in the CD group compared to the control group 
without CD (Study I, II & III). 
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7 FUTURE PERSPECTIVES     
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The findings in this thesis indicate there is a need to develop an efficient oral care program 
for the patients with CD patients, particularly for men and specially focused on dental caries. 
Further studies may include deep interviews to investigate the oral hygiene, diet habits and 
also aim to optimize smoking cessation. 
Furthermore, there is also a need for qualitative studies to attain a deeper understanding of 
CD, in terms of how the patients perceive their oral health and to identify strategies for 
maintenance care. Another important topic is to analyse behavioural aspects regarding why 
the CD patients clearly showed an increased use of tobacco compared to controls, since this 
is both an important risk factor for CD and periodontitis. Smoking cessation is one of the 
modifiable factors, where dental hygienists play an important role to promote better oral 
health and there are also cost effective benefits for public health. One strategy could be to 
use motivational counselling to explore patient’s thoughts in order to create a plan of 
smoking cessation, as well as maintaining regular routines for oral hygiene. It is also of 
interest to further investigate the gender differences.  
We plan to investigate the periodontal condition in CD patients more thoroughly regarding 
the microflora and several inflammatory biomarkers in gingival crevicular fluid and saliva, 
which are associated with the pathogenesis of many inflammatory diseases.  
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